Singapore markets closed

AxoGen, Inc. (0HKD.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
6.56-0.24 (-3.53%)
At close: 03:12PM BST
Full screen
Previous close6.80
Open6.52
Bid0.00 x N/A
Ask0.00 x N/A
Day's range6.52 - 6.56
52-week range3.50 - 10.82
Volume9
Avg. volume424
Market cap2.452M
Beta (5Y monthly)1.02
PE ratio (TTM)N/A
EPS (TTM)-0.77
Earnings date02 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

    ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™. “We are excited to expand our offering in nerve protection with the introduction of this resorbable barrier to support the critical phases of healing for nerve injuries,” said Karen Zaderej, chairman, CEO,

  • GlobeNewswire

    Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

    ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report first quarter 2024 financial results on Thursday, May 2, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conference call

  • Simply Wall St.

    Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long

    AxoGen, Inc. ( NASDAQ:AXGN ) is possibly approaching a major achievement in its business, so we would like to shine...